{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:10:52Z","timestamp":1791843052224,"version":"4.3.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03743-3","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:03:09Z","timestamp":1729782189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Everolimus on cystic kidney disease burden reduction in pediatric tuberous sclerosis complex patients: a case series"],"prefix":"10.1186","volume":"25","author":[{"given":"Sumona","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis Richard","family":"Feldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"3743_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1258-3","author":"JP Z\u00f6llner","year":"2020","unstructured":"Z\u00f6llner JP, Franz DN, Hertzberg C, Nabbout R, Rosenow F, Sauter M, Schubert-Bast S, Wiemer-Kruel A. A Strzelczyk. A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet J Rare Dis. 2020. https:\/\/doi.org\/10.1186\/s13023-019-1258-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3743_CR2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20186972","author":"LKL Portocarrero","year":"2018","unstructured":"Portocarrero LKL, Quental KN, Samorano LP, Prado de Oliveira ZN, Rivitti-Machado MC. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018. https:\/\/doi.org\/10.1590\/abd1806-4841.20186972.","journal-title":"An Bras Dermatol"},{"key":"3743_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1635457","author":"L Lechuga","year":"2019","unstructured":"Lechuga L. Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures. Expert Rev Neurother. 2019. https:\/\/doi.org\/10.1080\/14737175.2019.1635457.","journal-title":"Expert Rev Neurother"},{"key":"3743_CR4","unstructured":"Food and Drug Administration. FDA approves everolimus for tuberous sclerosis complex-associated partial-onset seizures. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-everolimus-tuberous-sclerosis-complex-associated-partial-onset-seizures (2018). Accessed 21 June 2024."},{"key":"3743_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.581102","author":"K Bobeff","year":"2021","unstructured":"Bobeff K, Krajewska K, Baranska D, Katarzyna K, Jozwiak S, Mlynarski W. Maintenance therapy with Everolimus for Subependymal Giant Cell Astrocytoma in patients with tuberous sclerosis \u2013 final results from the EMINENTS Study. Frontiers. 2021. https:\/\/doi.org\/10.3389\/fneur.2021.581102.","journal-title":"Frontiers"},{"key":"3743_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011272.pub2","author":"TH Sasongko","year":"2016","unstructured":"Sasongko TH, Ismail NF, Sabidi-Hussin Z. Rapamycin and rapalogs for tuberous sclerosis complex. Cochrane Database Syst Rev. 2016. https:\/\/doi.org\/10.1002\/14651858.CD011272.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3743_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy132","author":"JJ Bissler","year":"2019","unstructured":"Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg A, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Kingswood JC. Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2. Nephrol Dial Transpl. 2019. https:\/\/doi.org\/10.1093\/ndt\/gfy132.","journal-title":"Nephrol Dial Transpl"},{"key":"3743_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61767-X","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K. Everolimus for Angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013. https:\/\/doi.org\/10.1016\/S0140-6736(12)61767-X.","journal-title":"Lancet"},{"key":"3743_CR9","doi-asserted-by":"publisher","DOI":"10.1159\/000104818","author":"M Wu","year":"2007","unstructured":"Wu M 1, Wahl PR, Hir ML, Wackerle-Men Y, Wuthrich RP, Serra AL. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press Res. 2007. https:\/\/doi.org\/10.1159\/000104818.","journal-title":"Kidney Blood Press Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03743-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03743-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03743-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:04:45Z","timestamp":1729782285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03743-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3743"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03743-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require an ethics approval per the Saint Louis University Institutional Review Board guidelines on case reports and case series.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients and their legal guardians for publication of this case series.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}